Next CAPA Meeting Thursday March 4th
Our first meeting for 2010 has taken a while to finally appear, but it is here. We will be having a talk on buprenorphine given by William Nemeth, MD. Fore more details, visit our Facebook Fan Page or our Website. If you are not receiving e-vites, please reach out to our secretary Tara Penny. Remember if your membership is not current with TPA or CAPA, you will not be receiving the e-vites. You can always join now by visiting the TPA website, which is just about to get revamped. Many of the CAPA members and other local pharmacists have been helping TPA get ready for their annual meeting, which will be held in Austin, TX, this year. CAPA is the local chapter of the Texas Pharmacy Association that will be co-hosting the event. If you are interested in contributing to the event, make sure to reach out to Mark Zamutt, one of our local members. We are also looking for more sponsors for our meetings. Please contact our program director to sponsor any future events. You can see the current schedule of our meetings page of the CAPA website. If you are interested in sponsoring one of our meetings, please do not hesitate to contact us. We are looking forward to seeing everyone at D&B on Thursday evening.

[Comments...]

 

Pharmacists and health care reform
A member of CAPA passed along this quick read from Kaiser Health which describes the LA Times article on pharmacists in the health care reform movement. Take the time to read the article and see for yourself why we need to stand up as a profession and show why we can be the experts in managing patient’s medication therapy and medical conditions. See how pharmacists can achieve those positive patient outcomes by filling in the gaps that current health care solutions do not fill. Pharmacists Could Play Important Role In Reform Thank you to Scott Griggs for sharing the article to the rest of us. If you have something you would like to share with the rest of your fellow CAPA members do not hesitate to send us an e-mail with a link and any description you would like to include in the discussion.

[Comments...]